ID: ALA4217384
Chembl Id: CHEMBL4217384
PubChem CID: 122662633
Max Phase: Preclinical
Molecular Formula: C24H32O2
Molecular Weight: 352.52
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(C)=CCC/C(C)=C/CCC1=C[C@H](c2ccc(C(C)C)cc2)OC1=O
Standard InChI: InChI=1S/C24H32O2/c1-17(2)8-6-9-19(5)10-7-11-22-16-23(26-24(22)25)21-14-12-20(13-15-21)18(3)4/h8,10,12-16,18,23H,6-7,9,11H2,1-5H3/b19-10+/t23-/m1/s1
Standard InChI Key: BJVIHVBQYYYUPN-ALMVOQMYSA-N
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
| Molecular Weight: 352.52 | Molecular Weight (Monoisotopic): 352.2402 | AlogP: 6.81 | #Rotatable Bonds: 8 |
| Polar Surface Area: 26.30 | Molecular Species: NEUTRAL | HBA: 2 | HBD: ┄ |
| #RO5 Violations: 1 | HBA (Lipinski): 2 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): 1 |
| CX Acidic pKa: 13.50 | CX Basic pKa: ┄ | CX LogP: 7.28 | CX LogD: 7.28 |
| Aromatic Rings: 1 | Heavy Atoms: 26 | QED Weighted: 0.38 | Np Likeness Score: 2.09 |
| 1. Wang K, Bao L, Zhou N, Zhang J, Liao M, Zheng Z, Wang Y, Liu C, Wang J, Wang L, Wang W, Liu S, Liu H.. (2018) Structural Modification of Natural Product Ganomycin I Leading to Discovery of a α-Glucosidase and HMG-CoA Reductase Dual Inhibitor Improving Obesity and Metabolic Dysfunction in Vivo., 61 (8): [PMID:29634260] [10.1021/acs.jmedchem.8b00107] |
Source(1):
